The product will be available in USP 67 mg, 134 mg and 200 mg
Glenmark Pharmaceuticals received final approval by US FDA for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor Micronised Capsules, 67 mg, 134 mg, and 200 mg of AbbVie.
According to IMS Health sales data for the 12 month period ending February 2017, the Tricor Micronised capsules, 67 mg, 134 mg and 200 mg market achieved annual sales of approximately $97.5 million.
- Advertisement -
Comments are closed.